Valproate-induced hyperammonemic encephalopathy

J Am Acad Child Adolesc Psychiatry. 2004 Aug;43(8):926-7. doi: 10.1097/01.chi.0000129217.79887.c8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aggression / drug effects
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / pharmacokinetics
  • Anticonvulsants / toxicity*
  • Attention Deficit and Disruptive Behavior Disorders / blood
  • Attention Deficit and Disruptive Behavior Disorders / chemically induced
  • Attention Deficit and Disruptive Behavior Disorders / diagnosis
  • Child
  • Diagnosis, Differential
  • Dibenzothiazepines / administration & dosage
  • Dibenzothiazepines / pharmacokinetics
  • Dibenzothiazepines / toxicity
  • Disruptive, Impulse Control, and Conduct Disorders / blood
  • Disruptive, Impulse Control, and Conduct Disorders / diagnosis
  • Disruptive, Impulse Control, and Conduct Disorders / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Therapy, Combination
  • Electroencephalography / drug effects
  • Humans
  • Hyperammonemia / blood
  • Hyperammonemia / chemically induced*
  • Hyperammonemia / diagnosis
  • Lithium Chloride / administration & dosage
  • Lithium Chloride / pharmacokinetics
  • Lithium Chloride / toxicity
  • Liver Function Tests
  • Male
  • Neurotoxicity Syndromes / blood
  • Neurotoxicity Syndromes / diagnosis*
  • Quetiapine Fumarate
  • Valproic Acid / administration & dosage
  • Valproic Acid / pharmacokinetics
  • Valproic Acid / toxicity*

Substances

  • Anticonvulsants
  • Dibenzothiazepines
  • Quetiapine Fumarate
  • Valproic Acid
  • Lithium Chloride